Cart
sales@molnova.com
Cbl-b-IN-5
CAS No. 2368835-59-8
Cbl-b-IN-5( —— )
Catalog No. M36958 CAS No. 2368835-59-8
Cbl-b-IN-5 is a potent CPL-B inhibitor with IC50 values between 3 and 10 μM. Cbl-b-IN-5 has been used to study cancer and diseases related to the immune system.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 116 | Get Quote |
|
| 5MG | 178 | Get Quote |
|
| 10MG | 278 | Get Quote |
|
| 25MG | 548 | Get Quote |
|
| 50MG | 1003 | Get Quote |
|
| 100MG | 1404 | Get Quote |
|
| 500MG | 2817 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameCbl-b-IN-5
-
NoteResearch use only, not for human use.
-
Brief DescriptionCbl-b-IN-5 is a potent CPL-B inhibitor with IC50 values between 3 and 10 μM. Cbl-b-IN-5 has been used to study cancer and diseases related to the immune system.
-
DescriptionCbl-b-IN-5 (compound 6) is a Cbl-b inhibitor (IC50=3-10 μM). Cbl-b-IN-5 has the potential to be used in the study of cancer and related diseases amenable to immune system modulation.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2368835-59-8
-
Formula Weight339.42
-
Molecular FormulaC17H17N5OS
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (294.63 mM; Ultrasonic )
-
SMILESO=C(NC1=CC=CC(=C1)C(SC2=NN=CN2C)C)C3=NC=CC=C3
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Paul A. Barsanti, et al. Inhibitors of cbl-b and methods of use thereof. Patent WO2019148005A1.
molnova catalog
related products
-
Butein
Butein, a plant polyphenol, is isolated from Rhus verniciflua. It can inhibit the activation of protein tyrosine kinase, NF-κB and STAT3, and also can inhibit EGFR.
-
Mirin
A small molecule inhibitor of MRN (Mre11-Rad50-Nbs1) pathway that inhibits Mre11-associated exonuclease activity.
-
TLR1
TLR1 is a cell-penetrating Toll/IL-1 receptor/resistance (TIR) domain/BB-Loop mimic and inhibits IL-1 receptor-mediated responses.
